212 related articles for article (PubMed ID: 22717543)
21. Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.
Furuhashi M; Hiramitsu S; Mita T; Omori A; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Matsumoto M; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
Lipids Health Dis; 2016 Jan; 15():5. PubMed ID: 26754658
[TBL] [Abstract][Full Text] [Related]
22. Low adiponectin level in young normotensive men with a family history of essential hypertension.
Furuhashi M; Ura N; Higashiura K; Miyazaki Y; Murakami H; Hyakukoku M; Shimamoto K
Hypertens Res; 2005 Feb; 28(2):141-6. PubMed ID: 16025741
[TBL] [Abstract][Full Text] [Related]
23. Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus.
Li YY; Xiao R; Li CP; Huangfu J; Mao JF
Med Sci Monit; 2015 Feb; 21():426-31. PubMed ID: 25659997
[TBL] [Abstract][Full Text] [Related]
24. Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives.
Miyazaki Y; Hirata A; Murakami H; Fukuoka M; Agata J; Higashiura K; Masuda A; Ura N; Shimamoto K
Am J Hypertens; 1998 Sep; 11(9):1056-64. PubMed ID: 9752890
[TBL] [Abstract][Full Text] [Related]
25. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers.
Karakas SE; Almario RU; Kim K
Metabolism; 2009 Jul; 58(7):1002-7. PubMed ID: 19394980
[TBL] [Abstract][Full Text] [Related]
26. Plasma noradrenaline concentration and pressor response to infused noradrenaline in patients with borderline hypertension, and mild or moderate essential hypertension.
Iimura O; Kikuchi K; Sato S
Jpn Circ J; 1984 Feb; 48(2):159-67. PubMed ID: 6700112
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of hyperinsulinemia in young, nonobese Japanese men.
Masuo K; Mikami H; Ogihara T; Tuck ML
J Hypertens; 1997 Feb; 15(2):157-65. PubMed ID: 9469791
[TBL] [Abstract][Full Text] [Related]
28. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.
Tan M; Korkmaz H; Aydın H; Kumbul Doğuç D
Turk J Med Sci; 2019 Oct; 49(5):1490-1497. PubMed ID: 31651119
[TBL] [Abstract][Full Text] [Related]
29. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.
Hsu BG; Chen YC; Lee RP; Lee CC; Lee CJ; Wang JH
Circ J; 2010 Feb; 74(2):327-31. PubMed ID: 20009357
[TBL] [Abstract][Full Text] [Related]
30. Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.
Furuhashi M; Hiramitsu S; Mita T; Fuseya T; Ishimura S; Omori A; Matsumoto M; Watanabe Y; Hoshina K; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
J Lipid Res; 2015 Dec; 56(12):2372-80. PubMed ID: 26467280
[TBL] [Abstract][Full Text] [Related]
31. Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.
Ning H; Tao H; Weng Z; Zhao X
Acta Diabetol; 2016 Dec; 53(6):891-898. PubMed ID: 27147422
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of blood pressure regulating endocrinological factors in elderly essential hypertensives].
Shimamoto K; Hirata A; Iimura O
Nihon Ronen Igakkai Zasshi; 1994 Dec; 31(12):910-5. PubMed ID: 7699936
[TBL] [Abstract][Full Text] [Related]
33. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population.
Ishimura S; Furuhashi M; Watanabe Y; Hoshina K; Fuseya T; Mita T; Okazaki Y; Koyama M; Tanaka M; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Miura T
PLoS One; 2013; 8(11):e81318. PubMed ID: 24278421
[TBL] [Abstract][Full Text] [Related]
34. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.
Mita T; Furuhashi M; Hiramitsu S; Ishii J; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
Obesity (Silver Spring); 2015 Feb; 23(2):359-67. PubMed ID: 25521833
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of adipocyte fatty acid-binding protein in placenta, serum and umbilical cord blood in preeclampsia].
Yan JY; Wang XJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Dec; 45(12):885-90. PubMed ID: 21211417
[TBL] [Abstract][Full Text] [Related]
36. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
[TBL] [Abstract][Full Text] [Related]
37. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
38. FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
[TBL] [Abstract][Full Text] [Related]
39. Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin.
Baran A; Kiluk P; Świderska M; Maciaszek M; Myśliwiec H; Flisiak I
Lipids; 2019 Aug; 54(8):445-452. PubMed ID: 31281982
[TBL] [Abstract][Full Text] [Related]
40. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
